मैट्रिक्स
 
 
न्यूट्राप्लस इंडिया > कंपनी इतिहास > Pharmaceuticals > कंपनी इतिहास का न्यूट्राप्लस इंडिया - बीएसई: 524764, NSE: N.A

न्यूट्राप्लस इंडिया

बीएसई: 524764  |  NSE: N.A  |  ISIN: INE230G01020  |  Pharmaceuticals

कंपनी इतिहास - न्यूट्राप्लस इंडिया
NUTRAPLUS PRODUCTS (INDIA) LIMITED was originally incorporated as a
 private limited company on 6th February 1990 with the Registrar of
 Companies, Maharashtra at Bombay.  It was subsequently converted into
 a Public Limited Company with effect from 13th June 1992 in terms of
 the resolution passed in the Extra Ordinary General Meeting of the
 Company held on 28th May 1992.
 
 The Company is implementing a project for the manufacture of
 veterinary bulk drugs namely Dimetridazole (DMZ) and Dinitolmide
 (DOT) at M.I.D.C., Tarapur.  Initially the Company proposed to set up
 manufacturing facilities for manufacture of Methyl Nitro Imidazole, an
 intermediate of DMZ with installed capacity of 240 MT per annum at a
 cost of Rs.123.66 Lakhs, for which it was sanctioned a term Loan of
 Rs.60 Lakhs from Maharashtra State Financial Corporation (MSFC).
 
 But now the Company has decided to go in for production of
 Dimetridazole (DMZ) and Dinitolmide (DOT) with installed capacities
 of 160 MT and 300 MT respectively per annum due to high value
 addition in these products, than their intermediates, huge demand and
 export potential for these products, being veterinary bulk drugs and
 there being few units manufacturing these bulk drugs in the organised
 sector and also because these products are not under any government
 controls with regard to manufacturing, pricing, selling or
 distribution unlike other bulk drugs.
 
 2014
 -Company has changed its name from Nutraplus Products (India) Ltd to
 Nutraplus India Ltd.                                                 
      
                                          
 2015
 -The Company have opened a corporate office Nutraplus India Limited
 201/202, 2nd Floor, Planet Industrial Estate, Subhash Road, Vile
 Parle (East), Mumbai - 400057. Whereas the Registered Office of the
 Company will remain the same i.e.:Nutraplus India Limited,Vakil
 Villa, 7-A, Society Road End, Jogeshwari (E), Mumbai - 400060
 
 2016
 -Nutraplus India as commenced commercial production in its new plant
 at Tarapur for anti-malarial drug LUMEFANTRINE.
स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • BREAKING NEWS LOWER : मॉब लिंचिंग को राजनीतिक रूप देना सही नहीं
  • BREAKING NEWS LOWER : मॉब लिंचिंग की घटनाएं पहले भी होती रही हैं
  • BREAKING NEWS LOWER : 2024 के पहले देशभर में NRC लागू कर दी जाएगी
  • BREAKING NEWS LOWER : NRC भी एक अहम चुनावी मुद्दा होगा
  • BREAKING NEWS LOWER : UN कन्वेंशन, नियमों के तहत NRC का काम होगा
  • BREAKING NEWS LOWER : अयोध्या मसले पर SC का फैसला सभी को मान्य होगा
  • BREAKING NEWS LOWER : स्लोडाउन सिर्फ भारत में नहीं, ये ग्लोबल मंदी
  • BREAKING NEWS LOWER : ग्लोबल मंदी से भारत अछूता नहीं रह सकता
  • BREAKING NEWS LOWER : दूसरे देशों से भारत की तुलना सही नहीं
  • BREAKING NEWS LOWER : अच्छे मॉनसून से इकोनॉमी में आगे सुधार दिखेगा

अभी देखें

टक्कर

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 06, 2018)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo

Powerful mix of both trader and investor packs with timely expert advice.

Technical

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental

For all investors looking to unearth stocks that are poised to move.